Sevoflurane Inhalational Induction and Maintenance — Competitive Intelligence Brief

Sevoflurane Inhalational Induction and Maintenance (Sevoflurane Inhalational Induction and Maintenance) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Volatile anesthetic agent. Area: Anesthesiology.

marketed Volatile anesthetic agent GABA receptors, NMDA receptors, potassium channels Anesthesiology Small molecule

Target snapshot

Sevoflurane Inhalational Induction and Maintenance (Sevoflurane Inhalational Induction and Maintenance) — Abbott. Sevoflurane is a volatile anesthetic that depresses the central nervous system by enhancing inhibitory GABA neurotransmission and inhibiting excitatory glutamate signaling.

Comparator set (2 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Sevoflurane Inhalational Induction and Maintenance TARGET	Sevoflurane Inhalational Induction and Maintenance	Abbott	marketed	Volatile anesthetic agent	GABA receptors, NMDA receptors, potassium channels
Desflurane Inhalant Product	Desflurane Inhalant Product	Sichuan Provincial People's Hospital	marketed	Volatile inhalational anesthetic	GABA receptors, NMDA receptors, potassium channels
General sevoflurane anaesthesia	General sevoflurane anaesthesia	KK Women's and Children's Hospital	phase 3	Volatile anesthetic agent	GABA-A receptor, NMDA glutamate receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Volatile anesthetic agent class)

1. Abbott · 1 drug in this class
2. KK Women's and Children's Hospital · 1 drug in this class